These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11103926)

  • 21. The iterative use of economic evaluation as part of the process of health technology assessment.
    Sculpher M; Drummond M; Buxton M
    J Health Serv Res Policy; 1997 Jan; 2(1):26-30. PubMed ID: 10180650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on the cost-effectiveness of coronary revascularization: introducing the simultaneous mimic health status model.
    Lee JS; Bailey MJ; Jeong J; Mauldin PD; Weintraub WS
    Health Econ; 1997; 6(6):613-23. PubMed ID: 9466143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of stents, balloon angioplasty, and surgery for the treatment of branch pulmonary artery stenosis.
    Trant CA; O'Laughlin MP; Ungerleider RM; Garson A
    Pediatr Cardiol; 1997; 18(5):339-44. PubMed ID: 9270100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
    O'Hagan A; Stevens JW
    Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating country-specific cost-effectiveness from multinational clinical trials.
    Willke RJ; Glick HA; Polsky D; Schulman K
    Health Econ; 1998 Sep; 7(6):481-93. PubMed ID: 9809707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.
    Cohen DJ; Taira DA; Berezin R; Cox DA; Morice MC; Stone GW; Grines CL
    Circulation; 2001 Dec; 104(25):3039-45. PubMed ID: 11748097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
    Conigliani C
    Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
    Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
    Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
    Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
    Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States.
    Bosch JL; Haaring C; Meyerovitz MF; Cullen KA; Hunink MG
    AJR Am J Roentgenol; 2000 Aug; 175(2):517-21. PubMed ID: 10915706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and long-term cost implications of coronary stenting.
    Peterson ED; Cowper PA; DeLong ER; Zidar JP; Stack RS; Mark DB
    J Am Coll Cardiol; 1999 May; 33(6):1610-8. PubMed ID: 10334432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investment appraisal approach to clinical trial design.
    Backhouse ME
    Health Econ; 1998 Nov; 7(7):605-19. PubMed ID: 9845254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.
    Mantopoulos T; Mitchell PM; Welton NJ; McManus R; Andronis L
    Eur J Health Econ; 2016 Nov; 17(8):927-938. PubMed ID: 26445961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer.
    Griffin S; Bojke L; Main C; Palmer S
    Value Health; 2006; 9(2):123-31. PubMed ID: 16626416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction.
    Suryapranata H; Ottervanger JP; Nibbering E; van 't Hof AW; Hoorntje JC; de Boer MJ; Al MJ; Zijlstra F
    Heart; 2001 Jun; 85(6):667-71. PubMed ID: 11359749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial.
    Weaver WD; Reisman MA; Griffin JJ; Buller CE; Leimgruber PP; Henry T; D'Haem C; Clark VL; Martin JS; Cohen DJ; Neil N; Every NR
    Lancet; 2000 Jun; 355(9222):2199-203. PubMed ID: 10881893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.